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these factors in the modulation of neoan-
giogenesis. In addition, it remains to be
determined whether these peptides,
such as dysplasia-specific homing pep-
tide CSRPRRSEC, play any significant
role in wound healing, tissue revascular-
ization after ischemia, or whether this
homing is a salient feature of tumors.
Taken together, these findings set
forth an enticing hypothesis of a func-
tional vascular heterogeneity that can be
studied and used in the future to under-
stand the underlying pathogenesis of
tumor neoangiogenic processes. This
approach will also provide for new
molecular targets for radiographic tumor
detection and molecularly directed
chemotherapeutic drug delivery and
drug sensitivity testing. Given the fidelity
in homing of these peptides to their vas-
cular targets, fusion of a specific peptide
with an antiangiogenic agent will facili-
tate delivery of high concentrations of a
toxin to disrupt tumor vessels. In light of
the unparalleled specificity of phage
peptides, there is no doubt that this tech-
nology will allow us to identify stage-spe-
cific tumor and organ-specific vascular
zip codes. This will facilitate identification
of therapeutic targets to block tumor
angiogenesis and inhibit angiogenic
switches with minimal toxicity to other tis-
sue organs, such as those during
postnatal development or physiologically
regenerative processes.
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Cancer has long been thought of as a
multistep process, involving cooperation
between several oncogenic events and
mutations in tumor suppressors to yield
full-blown cellular transformation and
metastasis (Hanahan and Weinberg,
2000). Drosophila possesses ideal tools
to study the clonal effects of multiple
genetic manipulations on populations of
cells alongside phenotypically normal
cells. However, its potential for studying
the stepwise nature of the transformation
process had so far been largely untapped.
This looks set to change with the publi-
cation of two complementary reports by
the laboratories of Tian Xu and Helena
Richardson focusing on cooperation
between multiple genetic events to pro-
mote neoplastic growth and metastasis
(Brumby and Richarson, 2003; Pagliarini
and Xu, 2003).
These studies were facilitated by the
use of the MARCM technique (Lee and
Luo, 2001). Importantly, the MARCM
technique allows the generation, in a
heterozygous animal, of clones of cells
that (1) are homozygous mutant for vari-
ous mutations, (2) overexpress a trans-
gene(s) of interest, and (3) are labeled
positively with a GFP marker. Thus, the
MARCM technique is a versatile tool with
which the consequences of multiple
genetic manipulations upon positively
marked cells can be examined in vivo. In
both studies, the formation of these
clones was targeted to the eye imaginal
disc.
A model for metastasis in Drosophila
The Ras protooncogene is activated in
about 30% of human cancers (Hanahan
and Weinberg, 2000). Ras has been
implicated in the metastatic process in
mammalian systems, though its precise
in vivo contribution is not fully under-
Modeling transformation and metastasis in Drosophila
Transformation and metastasis are complex, multistep processes.Two recent papers exploit powerful Drosophila genetics
techniques to explore cooperation between multiple genetic manipulations and to model these processes. In particular,
oncogenic Ras is found to collaborate with disruption of cell polarity to trigger massive neoplasia and metastasis. These
studies promise further progress in research into the causes of cancer.
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stood (Bernards and Weinberg, 2002). In
Drosophila, Ras is required for growth
and proliferation, cell survival, as well as
the differentiation of many cell types
(Baker, 2001). Expression of an activat-
ed form of Ras (RasV12) triggers exces-
sive growth and proliferation, but is
insufficient to induce eye imaginal disc
cells to become invasive and metastatic.
Pagliarini and Xu screened existing mutant
collections for mutations that conferred
metastatic potential to Ras-expressing
cells. Using this approach, they demon-
strated that disruption of apico-basal
polarity cooperates with activated Ras to
induce metastasis. In particular, loss of
the cell polarity gene scribble (scrib) 
in Ras-expressing cells disrupted the
epithelial structure of the eye imaginal
disc and led to progressive invasion of
these cells into neighboring structures
(particularly the ventral nerve chord).
Excitingly, these cells could form foci at
remote sites within the larval body (see
Figure 1).
For Brumby and Richardson, the
starting point was scrib, which, they
show, can collaborate with either RasV12
or an activated form of Notch (NotchACT)
to promote neoplastic growth. Their
study focused on the mechanism of this
uncontrolled neoplastic growth, rather
than tissue invasion and formation of
secondary foci.
Cell polarity and tumor suppression
in Drosophila
Early attempts at using Drosophila as
a model for cancer yielded a series 
of genes which, when homozygous,
caused massive proliferation of imaginal 
discs (Humbert et al., 2003). For two 
of these early tumor suppressors,
lethal(2)giant larvae (lgl) and discs large
(dlg), as well as the more recently identi-
fied scrib, this excessive growth is
accompanied by a loss of epithelial
apico-basal polarity. Scrib, Lgl, and Dlg
function together to establish basolateral
domain identity by antagonizing the
function of another group of proteins, 
the Bazooka (Baz)/DmPAR6/DaPKC
(Drosophila atypical PKC) complex. The
Baz complex sets the position of the
adherens junctions and recruits the
Crumbs (Crb)/Stardust (Sdt) complex
apically to counter the activity of Scrib
and its partners (see Humbert et al.,
2003; Johnson and Wodarz, 2003). The
exact biochemical mechanisms involved
have not yet been elucidated. However,
these genes are certainly relevant to
mammalian polarity since, for example,
human scribble can rescue the mutant
phenotype of its fly counterpart (Dow et
al., 2003).
Pagliarini and Xu suggest that loss of
cell polarity in general, rather than
specific disruption of the Scrib/Lgl/Dlg
group, is responsible for cooperation 
with Ras since mutations in baz or sdt
also induced invasiveness in coopera-
tion with Ras.
Mechanistic aspects of cooperation
In scrib homozygous mutants, cells lose
apico-basal polarity, overproliferate, and
imaginal tissues form large amorphous
masses that tend to fuse with other tis-
sues (Humbert et al., 2003). However, in
a clonal situation, which mimics the clon-
al nature of cancer where mutant cells
are surrounded by phenotypically wild-
type cells, the outcome is quite different.
When clones of cells mutant for scrib are
created in heterozygous animals using
mitotic recombination, mutant cells do
indeed proliferate excessively, but these
excess cells are eliminated by JNK-
dependent apoptosis (Brumby and
Richarson, 2003). Thus, scrib clones fail
to overgrow in the presence of wild-type
cells (Brumby and Richarson, 2003;
Pagliarini and Xu, 2003).
A possible explanation for the coop-
eration between Ras and scrib could be
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Figure 1. Collaboration between separate genetic events leads to neoplasia and metastasis in Drosophila imaginal disc epithelial cells
Expression of activated Ras induces hyperplasia but cells only become metastatic when polarity is perturbed by loss of scribble.
ZA = Zonula Adherens.
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through Ras’ ability to promote growth,
proliferation, and cell survival, which 
has been well documented both in
Drosophila and vertebrates. However,
combined overexpression of E2F1/Dp,
which promotes cell cycle entry, with the
caspase inhibitor p35 failed to trigger
neoplasia and invasion in scrib mutant
cells (Brumby and Richarson, 2003;
Pagliarini and Xu, 2003). In addition,
mutations in the warts/lats tumor sup-
pressor, which potently triggers growth
and proliferation and blocks apoptosis,
do not make scrib cells metastasize
(Pagliarini and Xu, 2003). Thus, neopla-
sia and metastasis as a result of loss of
polarity depends on specific aspects of
Ras signaling, rather than a general abil-
ity to induce division and block death.
Brumby and Richardson show that acti-
vation of one branch of Ras downstream
signaling, the Raf/MAPK (mitogen acti-
vated protein kinase) pathway, is suffi-
cient to trigger neoplasia in scrib mutant
cells, whereas other Ras effectors, such
as PI3K (phosphoinositide 3-kinase) or
Ral, have no effect. The mechanism
underlying the specific requirement for
Ras activation in triggering neoplasia in
combination with scrib mutations will be
fascinating to study. Ras overexpression
is known to modify the adhesive proper-
ties of cells in clones in vivo, which may
be part of the cooperation mechanism
(Prober and Edgar, 2002).
The case of activated Notch is a little
more puzzling. Ectopic Notch activation
has clearly been shown to trigger uncon-
trolled growth of imaginal tissues (Go et
al., 1998). However, Notch has been
implicated in induction of (rather than
protection from) apoptosis. Brumby and
Richardson suggest that Notch’s ability
to cooperate with scrib may depend on
Ras function, though the mechanism is
unclear. It will be interesting to further
probe this question.
Does this represent a bona fide
model for mammalian metastasis? Clearly,
there are differences. For example, the
fly tracheal system (which brings oxygen
directly to the various organs) is quite dif-
ferent from the vertebrate circulatory
system. Thus extra- and intravasation,
both important aspects of the metastatic
process that allow dissemination of
tumor cells to remote sites, might not be
relevant to the fly model. However, 
scrib mutant RasV12-expressing cells
(RasV12/scrib−/− cells) were observed 
in tracheal branches, though the
mechanism of entry is not yet known
(Pagliarini and Xu, 2003).
Pagliarini and Xu present two addi-
tional lines of evidence that draw strong
parallels between their Drosophila metas-
tasis model and mammalian metastasis.
First, loss of E-Cadherin expression is a
feature of many invasive cancers, and
expression of Drosophila E-Cadherin is
reduced in RasV12/scrib−/− cells. Moreover,
expression of E-Cadherin efficiently
blocked metastasis of RasV12/scrib−/−
cells. Second, the ability of tumor cells to
degrade the extracellular matrix (ECM)
contributes to invasion and metastasis
(Hanahan and Weinberg, 2000). Using a
collagen-GFP protein trap and an anti-
Laminin antibody, Pagliarini and Xu show
that RasV12/scrib−/− cells are able to dis-
rupt the ECM. Thus, several key aspects
of mammalian metastasis are recapitu-
lated in the Drosophila model.
What next?
This work opens many exciting avenues
for future studies. How does cell polarity
affect neoplasia and metastasis? Loss of
cell adhesion is clearly a feature of mam-
malian cancer (Hanahan and Weinberg,
2000).The relative contributions to trans-
formation and metastasis of processes
such as loss of contact inhibition or mod-
ifications in cell signaling resulting from
polarity loss can readily be tackled in the
Drosophila model.
Another interesting aspect of this
work concerns the nature of JNK-depen-
dent apoptosis that limits growth of scrib
mutant tissues (Brumby and Richarson,
2003). This requires the presence of
neighboring wild-type cells and is remi-
niscent of the JNK-dependent apoptosis
elicited by cell competition or disruption
of tissue patterning cues (Adachi-Yamada
and O’Connor, 2002; Moreno et al.,
2002). One possible explanation is that
loss of polarity perturbs the transmission
of morphogenetic signals, thus triggering
apoptosis of aberrant cells. In addition,
little is currently known about scrib’s role
in repressing proliferation, which war-
rants further investigation.
The two groups propose comple-
mentary approaches to follow up on their
exciting results: a search for mutations in
new metastasis suppressors that confer
invasiveness to Ras-expressing cells as
well as a search for “oncogenic muta-
tions” that cooperate with scrib mutations
to promote neoplastic growth. The com-
bination of these screens should provide
exciting insights into the complexities of
cancer biology.
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